Brief: Sedana Medical Receives FDA Approval For Early Access Program In U.S.

Sedana Medical AB (publ)

23/04/2025 07:06

April 23 (Reuters) - Sedana Medical AB (publ) SEDANA.ST:

SEDANA MEDICAL RECEIVES FDA APPROVAL FOR EARLY ACCESS PROGRAM IN THE U.S.

WILL PROVIDE ITS INVESTIGATIONAL PRODUCTS FREE OF CHARGE TO PARTICIPATING HOSPITALS

FIRST PATIENTS ARE EXPECTED TO BE TREATED IN SECOND HALF OF 2025

Source text: ID:nMFN7vp4qj

Further company coverage: SEDANA.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))